DACT2

Chr 6

dishevelled binding antagonist of beta catenin 2

Also known as: C6orf116, DAPPER2, DPR2, bA503C24.7

Predicted to enable several functions, including beta-catenin binding activity; delta-catenin binding activity; and protein kinase C binding activity. Predicted to be involved in several processes, including epithelial cell morphogenesis; inner medullary collecting duct development; and negative regulation of nodal signaling pathway. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…
0
Active trials
6
Pubs (1 yr)
P/LP submissions
P/LP missense
1.26
LOEUF
DN
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.26LOEUF
pLI 0.009
Z-score 1.11
OE 0.55 (0.271.26)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
1.40Z-score
OE missense 0.81 (0.740.88)
340 obs / 420.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.55 (0.271.26)
00.351.4
Missense OE?0.81 (0.740.88)
00.61.4
Synonymous OE?0.80
01.21.6
LoF obs/exp: 4 / 7.2Missense obs/exp: 340 / 420.9Syn Z: 2.25

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

DACT2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →